April 2019 FDA Recall Drug by Advanced Pharma Inc.
D-1251-2019 - Sub-potency

This Class II drug recall was voluntarily initiated by Advanced Pharma Inc. on April 26, 2019 for the product Drug. The FDA reported the reason for recall as sub-potency. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1251-2019

Reason for Recall
Sub-potency
Initiated
04-26-2019
Reported
05-08-2019
Quantity
560 bags

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Advanced Pharma Inc.
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Nationwide in the US
HYDROmorphone 20 mg/100 mL Injectable Solution, Hydromorphone HCl 20 mg 0.9% Sodium Chloride 100 mL, Sterile single use bag, Compounded Drug, Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404, NDC: 42852-221-10

Batch or Lot Expiration Information

Lot# Lot: 01/14/19 0215 22110P Exp. 04/29/2019